# Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy

> **NCT05636644** · — · UNKNOWN · sponsor: **Mei Zhang** · enrollment: 112 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Taxol

## Key facts

- **NCT ID:** NCT05636644
- **Lead sponsor:** Mei Zhang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-04
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-06-16
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2022-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05636644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05636644, "Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05636644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*